Skip to main content
Caplight Logo









Eugene Labs

Eugene Labs

Private
RichmondHealthcare & Life Scienceshttps://eugenelabs.com/

Last Round

Corporate Funding

Apr 22, 2025

Total Funding Raised

$2.69M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Eugene Labs is a digital healthcare company that offers at-home genetic tests, in-app counseling, carrier testing, and proactive cancer risk assessments.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Telemedicine, Biotechnology, D2C Brands

Business Model

B2C

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

at-home genetic testinggenetic counsellingreproductive carrier screeningpreventative health testhome DNA testcancer genetic testingtelehealthfertility genetic testdirect-to-consumer genetic testingD2C genetic testingprecision medicinedigital healthcouples carrier screeningB2B2C healthcareAI-augmented genomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eugene Labs Comparables

Compare Eugene Labs with similar companies based on industry and business-model similarity.

Eugene Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lumi Health
89%
GeneScreen Counseling
79%
Nucleus Genomics
78%

Eugene Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingApr 22, 2025
Series AJan 18, 2021

Key People

Founding team and executive leadership

Zoë Milgrom

Founder and Chief Clinical Officer

Founding Team

Kunal Kalro

Founder & CEO

Founding Team

Eugene Labs Investors

Notable investors and investment history

Eugene Labs investors
InvestorRounds
ALIAVIA VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 128% MoM, reaching 15.5K.

  • Jan 24, 2026

    Monthly visitors grew 205% MoM, reaching 15.1K.

Eugene Labs Filings

Explore SEC and related filing metadata, where available.

Eugene Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eugene Labs's valuation, stock price, and market status.

Is Eugene Labs a public or private company?

Eugene Labs is a private company.

What is the current stock price of Eugene Labs?

Eugene Labs is a private company with no public stock price. No recent secondary market data is available.

How much is Eugene Labs worth (valuation)?

Valuation information for Eugene Labs is not publicly available.

Can I buy Eugene Labs stock?

Eugene Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eugene Labs's last funding round?

Funding round information for Eugene Labs is not publicly available.

Who are the main investors in Eugene Labs?

Investor information for Eugene Labs is not publicly disclosed.

Will Eugene Labs IPO soon?

No public IPO plans have been announced for Eugene Labs.

How can I track Eugene Labs secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eugene Labs's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRichmond
Employee Range20
Year Founded2016
Last FundingApr 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?